Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review

Marta Cremonesi, Cristina Garibaldi, Robert Timmerman, Mahila Ferrari, Sara Ronchi, Chiara Maria Grana, Laura Travaini, Laura Gilardi, Anna Starzyńska, Delia Ciardo, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Maria Cristina Leonardi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Oesophageal cancer is an aggressive disease. The possibility to early stratify patients as responsive and non-responsive with a non-invasive method is extremely appealing. The uptake of Fluorodeoxyglucose (18F-FDG) in tumours, provided by positron emission tomography (PET) images, has been proved to be useful to assess the initial staging of the disease, recurrence, and response to chemotherapy and chemo-radiotherapy (CRT). In the last years, efforts have been focused on the possibility to use ad interim 18F-FDG-PET/CT (PETint) to evaluate response during radiation therapy. However, controversial findings have been reported, although some relevant results would support its use for individual therapeutic decision.The present review assembles the comprehensive literature of the last decade to evaluate whether and in which cases PETint may offer predictive potential in oesophageal cancer. All the analysed studies (13 studies, 697 patients) denoted PETint as a challenging examination for early assessment of outcomes during CRT. In particular, 8 studies advocated the predictivity of PETint, whilst 5 did not find any correlation between the interim variation of PET parameters and the pathological complete response and/or the clinical outcome. The reasons that possibly have caused contradictions among the studies demand further research with prospective and uniform protocols and methods of analysis to assess the predictive and prognostic value of PETint in oesophageal cancer.

Original languageEnglish (US)
JournalRadiotherapy and Oncology
DOIs
StateAccepted/In press - 2017

Fingerprint

Fluorodeoxyglucose F18
Esophageal Neoplasms
Positron-Emission Tomography
Radiotherapy
Therapeutic Uses
Outcome Assessment (Health Care)
Recurrence
Drug Therapy
Research
Neoplasms

Keywords

  • Ad-interim FDG-PET
  • Chemo-radiotherapy
  • Oesophageal cancer
  • Tumour response

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review. / Cremonesi, Marta; Garibaldi, Cristina; Timmerman, Robert; Ferrari, Mahila; Ronchi, Sara; Grana, Chiara Maria; Travaini, Laura; Gilardi, Laura; Starzyńska, Anna; Ciardo, Delia; Orecchia, Roberto; Jereczek-Fossa, Barbara Alicja; Leonardi, Maria Cristina.

In: Radiotherapy and Oncology, 2017.

Research output: Contribution to journalArticle

Cremonesi, M, Garibaldi, C, Timmerman, R, Ferrari, M, Ronchi, S, Grana, CM, Travaini, L, Gilardi, L, Starzyńska, A, Ciardo, D, Orecchia, R, Jereczek-Fossa, BA & Leonardi, MC 2017, 'Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review', Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2017.09.022
Cremonesi, Marta ; Garibaldi, Cristina ; Timmerman, Robert ; Ferrari, Mahila ; Ronchi, Sara ; Grana, Chiara Maria ; Travaini, Laura ; Gilardi, Laura ; Starzyńska, Anna ; Ciardo, Delia ; Orecchia, Roberto ; Jereczek-Fossa, Barbara Alicja ; Leonardi, Maria Cristina. / Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review. In: Radiotherapy and Oncology. 2017.
@article{990461488be4469b8abb7fdec4095cdb,
title = "Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review",
abstract = "Oesophageal cancer is an aggressive disease. The possibility to early stratify patients as responsive and non-responsive with a non-invasive method is extremely appealing. The uptake of Fluorodeoxyglucose (18F-FDG) in tumours, provided by positron emission tomography (PET) images, has been proved to be useful to assess the initial staging of the disease, recurrence, and response to chemotherapy and chemo-radiotherapy (CRT). In the last years, efforts have been focused on the possibility to use ad interim 18F-FDG-PET/CT (PETint) to evaluate response during radiation therapy. However, controversial findings have been reported, although some relevant results would support its use for individual therapeutic decision.The present review assembles the comprehensive literature of the last decade to evaluate whether and in which cases PETint may offer predictive potential in oesophageal cancer. All the analysed studies (13 studies, 697 patients) denoted PETint as a challenging examination for early assessment of outcomes during CRT. In particular, 8 studies advocated the predictivity of PETint, whilst 5 did not find any correlation between the interim variation of PET parameters and the pathological complete response and/or the clinical outcome. The reasons that possibly have caused contradictions among the studies demand further research with prospective and uniform protocols and methods of analysis to assess the predictive and prognostic value of PETint in oesophageal cancer.",
keywords = "Ad-interim FDG-PET, Chemo-radiotherapy, Oesophageal cancer, Tumour response",
author = "Marta Cremonesi and Cristina Garibaldi and Robert Timmerman and Mahila Ferrari and Sara Ronchi and Grana, {Chiara Maria} and Laura Travaini and Laura Gilardi and Anna Starzyńska and Delia Ciardo and Roberto Orecchia and Jereczek-Fossa, {Barbara Alicja} and Leonardi, {Maria Cristina}",
year = "2017",
doi = "10.1016/j.radonc.2017.09.022",
language = "English (US)",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review

AU - Cremonesi, Marta

AU - Garibaldi, Cristina

AU - Timmerman, Robert

AU - Ferrari, Mahila

AU - Ronchi, Sara

AU - Grana, Chiara Maria

AU - Travaini, Laura

AU - Gilardi, Laura

AU - Starzyńska, Anna

AU - Ciardo, Delia

AU - Orecchia, Roberto

AU - Jereczek-Fossa, Barbara Alicja

AU - Leonardi, Maria Cristina

PY - 2017

Y1 - 2017

N2 - Oesophageal cancer is an aggressive disease. The possibility to early stratify patients as responsive and non-responsive with a non-invasive method is extremely appealing. The uptake of Fluorodeoxyglucose (18F-FDG) in tumours, provided by positron emission tomography (PET) images, has been proved to be useful to assess the initial staging of the disease, recurrence, and response to chemotherapy and chemo-radiotherapy (CRT). In the last years, efforts have been focused on the possibility to use ad interim 18F-FDG-PET/CT (PETint) to evaluate response during radiation therapy. However, controversial findings have been reported, although some relevant results would support its use for individual therapeutic decision.The present review assembles the comprehensive literature of the last decade to evaluate whether and in which cases PETint may offer predictive potential in oesophageal cancer. All the analysed studies (13 studies, 697 patients) denoted PETint as a challenging examination for early assessment of outcomes during CRT. In particular, 8 studies advocated the predictivity of PETint, whilst 5 did not find any correlation between the interim variation of PET parameters and the pathological complete response and/or the clinical outcome. The reasons that possibly have caused contradictions among the studies demand further research with prospective and uniform protocols and methods of analysis to assess the predictive and prognostic value of PETint in oesophageal cancer.

AB - Oesophageal cancer is an aggressive disease. The possibility to early stratify patients as responsive and non-responsive with a non-invasive method is extremely appealing. The uptake of Fluorodeoxyglucose (18F-FDG) in tumours, provided by positron emission tomography (PET) images, has been proved to be useful to assess the initial staging of the disease, recurrence, and response to chemotherapy and chemo-radiotherapy (CRT). In the last years, efforts have been focused on the possibility to use ad interim 18F-FDG-PET/CT (PETint) to evaluate response during radiation therapy. However, controversial findings have been reported, although some relevant results would support its use for individual therapeutic decision.The present review assembles the comprehensive literature of the last decade to evaluate whether and in which cases PETint may offer predictive potential in oesophageal cancer. All the analysed studies (13 studies, 697 patients) denoted PETint as a challenging examination for early assessment of outcomes during CRT. In particular, 8 studies advocated the predictivity of PETint, whilst 5 did not find any correlation between the interim variation of PET parameters and the pathological complete response and/or the clinical outcome. The reasons that possibly have caused contradictions among the studies demand further research with prospective and uniform protocols and methods of analysis to assess the predictive and prognostic value of PETint in oesophageal cancer.

KW - Ad-interim FDG-PET

KW - Chemo-radiotherapy

KW - Oesophageal cancer

KW - Tumour response

UR - http://www.scopus.com/inward/record.url?scp=85030778555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030778555&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2017.09.022

DO - 10.1016/j.radonc.2017.09.022

M3 - Article

C2 - 29029833

AN - SCOPUS:85030778555

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

ER -